![]() |
Volumn 94, Issue 1, 2002, Pages 14-17
|
Clinical significance of plasma endostatin in acute myeloid leukemia/myelodysplastic syndrome
|
Author keywords
Acute myeloid leukemia; Angiogenesis; Endostatin; Myelodysplastic; Prognosis; Syndrome
|
Indexed keywords
ANGIOGENESIS INHIBITOR;
ENDOSTATIN;
ACUTE GRANULOCYTIC LEUKEMIA;
ARTICLE;
CANCER REGRESSION;
CANCER SURVIVAL;
CONTROLLED STUDY;
CORRELATION ANALYSIS;
DISEASE COURSE;
ENZYME LINKED IMMUNOSORBENT ASSAY;
HUMAN;
MAJOR CLINICAL STUDY;
MULTIVARIATE ANALYSIS;
MYELODYSPLASTIC SYNDROME;
PREDICTION;
PRIORITY JOURNAL;
PROGNOSIS;
PROTEIN BLOOD LEVEL;
ACUTE DISEASE;
ANTINEOPLASTIC AGENTS;
COLLAGEN;
COLLAGEN TYPE XVIII;
ENDOSTATINS;
ENZYME-LINKED IMMUNOSORBENT ASSAY;
HUMANS;
LEUKEMIA, MYELOID;
MYELODYSPLASTIC SYNDROMES;
PEPTIDE FRAGMENTS;
PROGNOSIS;
PROPORTIONAL HAZARDS MODELS;
REMISSION INDUCTION;
SURVIVAL ANALYSIS;
|
EID: 0036140648
PISSN: 0008543X
EISSN: None
Source Type: Journal
DOI: 10.1002/cncr.10200 Document Type: Article |
Times cited : (39)
|
References (20)
|